First National Bank of Omaha’s Emergent Biosolutions EBS Stock Holding History

First National Bank of Omaha’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,640	Closed	-$386K	–	331
2019 Q1	$386K	Sell	7,640 -60	-0.8%	-$3.54K	0.03%	271
2018 Q4	$456K	Sell	7,700 -1,875	-20%	-$121K	0.03%	258
2018 Q3	$630K	Sell	9,575 -25	-0.3%	-$1.46K	0.04%	318
2018 Q2	$485K	Buy	+9,600	New	+$500K	0.03%	338

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

First National Bank of Omaha's EBS Position: Q2 2019 in Review

First National Bank of Omaha sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 7,640 shares — an estimated $386K sold.

First National Bank of Omaha first reported a position in EBS in Q2 2018 and held it in 4 quarters. The position peaked at $630K in Q3 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

First National Bank of Omaha reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
First National Bank of Omaha sold 7,640 Emergent Biosolutions shares in Q2 2019, an estimated $386K.
First National Bank of Omaha first reported a position in Emergent Biosolutions in Q2 2018 and held it in 4 quarters.
First National Bank of Omaha's Emergent Biosolutions position peaked at $630K in Q3 2018.
233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on First National Bank of Omaha's 13F filing for Q2 2019, filed 10 Jul 2019.